Successful Market-Timing Mutual Funds
With the markets in turmoil, plenty of investors are frustrated. Stockholders wish they could sell shares before downturns and buy just as bull markets begin.
Diagnosis & Disease Information
MI Patients with CKD Get Worse Care
NEW ORLEANS—MI patients who have CKD are less likely to receive evidence-based therapies for MI and are more likely to die than those without CKD, Stephen D. Wiviott, MD, said at the 2008 scientific sessions of the American Heart Association.
New Data Needed on Anemia Drug for CKD Patients
AMAG Pharmaceuticals, Inc., of Lexington, Mass., has received a Complete Response letter from the FDA regarding ferumoxytol for the treatment of iron deficiency anemia (IDA) in CKD patients.
Fibrate Cleared to Manage Cholesterol in Combo with Statin
Abbott Laboratories, in Abbott Park, Ill., has received approval of Trilipix (fenofibric acid) delayed-release capsules for use along with diet to help lower triglycerides and LDL and raise HDL in patients with lipid problems.
New Recommendations on Evaluating CV Risk of Diabetes Drugs
The FDA has announced new recommendations on evaluating cardiovascular (CV) risk of drugs intended to treat type 2 diabetes, asking manufacturers to provide evidence that the therapy will not increase the risk of heart attacks and other events.
Injectable Drug for Advanced PCa Approved
Degarelix, an injectable treatment for advanced prostate cancer manufactured for Ferring Pharmaceuticals Inc., Parsippany, N.J., by Rentschler Biotechnologie Gmbh, Laupheim, Germany, has won approval from the FDA.
CROWNWeb: Next-Generation CPM Reporting
For more than four decades, the Centers for Medicare and Medicaid Services (CMS) has had as its mission the advancement of effective, up-to-date health-care coverage and the promotion of quality care for beneficiaries.
Factors Influencing Response to ESAs
Researchers are examining the role of iron-regulatory proteins in patients with CKD-related anemia
Robotic Single-Port Surgery Proves Successful
It improves range of motion and motor precision in ergonomically challenging surgical cases
Treating Bladder Ca with Sunitinib
The medication is being tested as adjuvant therapy in patients with locally advanced urothelial cancer.
- Loading...
Loading...
Loading... 
Loading...